Evidence map›Paper›PMID 38203401›Full record

ArticleInternational journal of molecular sciences2023

microRNA-Based Cancer Diagnosis and Therapy.

Hexin Chen

Abstract readEditorial
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Modulation of the cytoskeleton for cancer therapy.Frontiers in cell and developmental biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Hexin ChenDepartment of Biological Sciences, University of South Carolina, Columbia, SC 29208, USA.ORCID 0000-0001-9300-0859

Funding

Preventing adaptive drug resistance through Mediator kinase inhibitionR01CA266027 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI Hexin Chen, Mengqian Chen · 2022 to 2026
$3.0M
Nanoparticle delivered miR-489 rejuvenates anthracycline-based chemotherapyR21CA252360 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI CHEN, HEXIN, XU, PEISHENG · 2020 to 2021
$397k
NCI NIH HHS R01 CA266027NCI NIH HHS R01CA26602; R21CA252360NCI NIH HHS R21 CA252360
6 · The paper itself

Abstract

MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression post-transcriptionally by impeding mRNA translation or stability [...].

Indexed as

MicroRNAsNeoplasmsHumansProtein BiosynthesisMicroRNAs

Identifiers

PMID38203401
PMCPMC10778828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.